Renal vasculitis causes damage to the small blood vessels inside the kidneys and – when untreated – leads to a rapid loss of kidney function. In September 2015, Giles Walters and his colleagues in Australia updated the Cochrane Review of studies of treatments to induce and maintain disease remission for renal vasculitis. Listen to the podcast: Interventions for renal vasculitis in adults

Kidney Disease & Obesity Healthy Lifestyle for Healthy KidneysWorld Kidney Day is a global campaign aimed at raising awareness of the importance of our kidneys. This year World Kidney Day promotes education about the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that make preventive behaviours an affordable option.

Introductory workshop on implementation science with Jeremy Grimshaw

IgA nephropathy is a kidney condition, leading to kidney failure for many of those who are affected. About 10-20% of patients require dialysis or a kidney transplant within 10 years, and 30-40% within 20 years, from their disease onset. This long time between diagnosis and kidney failure makes it difficult to establish the most effective and safest treatment.In August 2015, Marinella Ruospo and her colleagues from Bari, Italy updated their Cochrane Review of immunosuppressive therapies and she tells us what they have found in this Evidence pod.

Cranberry is a popular natural treatment for urinary tract infections (UTIs), but does the evidence on its effectiveness stack up? 

Dr. Ravindra Prabhu has been awarded the 2016 Kenneth Warren Prize for the Cochrane review Interventions for dialysis patients with hepatitis C virus (HCV) infection.

Podcast: Cochrane author Davide Bolignano from Reggio Calabria in Italy, and his colleagues, examined relevant studies on treatments for adult polycystic kidney disease to assess the effects on patient outcomes:Interventions for preventing the progression of autosomal dominant polycystic kidney disease

Read David Mudge's Cochrane Editorial - Avoiding or stopping steroids in kidney transplant recipients: sounds good but does it work? - based on an update of the Cochrane review 'Steroid avoidance or withdrawal for kidney transplant recipients'.  David is Consultant Nephrologist and Associate Professor of Medicine, University of Queensland at Princess Alexandra Hospital and Editor, Cochrane Kidney and Transplant.

Haemodialysis is the most common treatment for kidney failure, but problems can arise with access to the patient’s bloodstream. A new Cochrane Review from January 2016 examines the evidence for preventing one of these problems, the development of a stenosis. The lead author of the review, Pietro Ravani, from the University of Calgary in Canada, describes the findings in this Evidence Pod.